Mesothelioma is primarily characterised by inactivating mutations in tumour suppressor genes such as BAP1, CDKN2A, NF2, SETD2, and TP53, while activating oncogene mutations are rare [8]. This evidence concerns the gene SETD2 and mesothelioma.